Product Information
LOVENOX 40 MG/0.4 ML SYRINGE is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $6.7750 per ML under NDC 00075801410. Its NADAC has been published 178 times since Oct 15, 2014.
FDA first approved this application on Mar 29, 1993. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the enoxaparin sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/.4mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00075801410
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
11/19/2025
Active Ingredients
ENOXAPARIN SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA020164FDA Approved
3/29/1993
TE Code
AP
On Market Since
3/29/1993
Pharmacological Classes
Price Statistics
The NADAC for LOVENOX 40 MG/0.4 ML SYRINGE has been published 178 times since Oct 15, 2014, and over the history we have for it it has declined 91.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.7750 per ML |
|---|---|
| All-time high | $79.4714 (Sep 16, 2015) |
| All-time low | $6.7750 (Nov 19, 2025) |
| 52-week high | $6.8235 |
| 52-week low | $6.7750 |
| Median price | $7.9073 |
| Average price | $27.2839 |
| Largest weekly change | -89.5% (Apr 17, 2024) |
| Weeks tracked | 178 |
| Tracking since | Oct 15, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sanofi-Aventis U.S. LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
enoxaparin sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Low Molecular Weight Heparin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOVENOX 40 MG/0.4 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for LOVENOX 40 MG/0.4 ML SYRINGE, manufactured by Sanofi-Aventis U.S. LLC, is $6.7750 per ML (NDC 00075801410), effective Sep 30, 2026.
How has the price of LOVENOX 40 MG/0.4 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for LOVENOX 40 MG/0.4 ML SYRINGE has declined 91.5%. It has been tracked across 178 weekly CMS publications since Oct 15, 2014.
What are the highest and lowest recorded NADAC prices for LOVENOX 40 MG/0.4 ML SYRINGE?
Since Oct 15, 2014, the NADAC for LOVENOX 40 MG/0.4 ML SYRINGE has ranged from a low of $6.7750 (Nov 19, 2025) to a high of $79.4714 (Sep 16, 2015), with a median of $7.9073 per ML.
Are there cheaper alternatives to LOVENOX 40 MG/0.4 ML SYRINGE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOVENOX 40 MG/0.4 ML SYRINGE in a comparable dosage form, but none are currently priced below it.
Who manufactures LOVENOX 40 MG/0.4 ML SYRINGE?
LOVENOX 40 MG/0.4 ML SYRINGE (NDC 00075801410) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.